Dimeditiapramine
Dimeditiapramine (Tiapamil) is a calcium channel blocker.[1] Tiapamil has been described as an "antianginal agent".
|  | |
|  | |
| Names | |
|---|---|
| Preferred IUPAC name 2-(3,4-Dimethoxyphenyl)-2-(3-{[2-(3,4-dimethoxyphenyl)ethyl]methylamino}propyl)-1λ6,3λ6-dithiane-1,1,3,3-tetrone | |
| Identifiers | |
| 3D model (JSmol) | |
| ChemSpider | |
| ECHA InfoCard | 100.054.992 | 
| PubChem CID | |
| UNII | |
| CompTox Dashboard (EPA) | |
| 
 | |
| Properties | |
| C26H37NO8S2 | |
| Molar mass | 555.70388 | 
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references | |
See also
    
    
References
    
- Cocco, G.; Strozzi, C.; Chu, D. (1979). "Human electropharmacology of the calcium antagonist dimeditiapramine (Ro 11-1781) in coronary patients". Clinical Cardiology. 2 (3): 212–6. doi:10.1002/clc.4960020307. PMID 509799. S2CID 24609271.
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

